## Apollo Hospitals Enterprise Limited (APOLLOHOSP) Stock Investment Report - December 20, 2024

**1. Company Overview:**

Apollo Hospitals Enterprise Limited (APOLLOHOSP) is a leading healthcare provider in India, listed on the National Stock Exchange of India (NSE) since January 10, 1996.  The company operates a network of hospitals, clinics, pharmacies, and other healthcare services, holding a significant position in the Indian healthcare sector.  Its industry is classified as "Hospital" within the broader Healthcare Services sector.

**2. Market Data Analysis:**

| Metric                     | Value          | Notes                                                              |
|-----------------------------|-----------------|----------------------------------------------------------------------|
| Current Price              | ₹7,244.90       | As of December 20, 2024, 16:00:00                               |
| Percentage Change (PChange) | -0.72%         | Compared to the previous close                                      |
| Pre-Open Activity          | ₹7,324.80       | Indicates a positive pre-open sentiment, but this is not a reliable indicator of the day's performance. |
| Week High                   | ₹7,545.00       | High for the week ending December 20, 2024                          |
| Week Low                    | ₹5,284.85       | Low for the week ending December 20, 2024                           |
| VWAP                        | ₹7,308.13       | Volume Weighted Average Price for the day                             |
| Sector PE                   | 87.67           | Price-to-Earnings ratio for the NIFTY 50 sector                     |
| Symbol PE                   | 87.67           | Price-to-Earnings ratio for APOLLOHOSP                               |
| Delivery Percentage         | 50.44%         | Indicates a moderate level of delivery-based trading                 |
| Market Depth                | Low             | Based on the provided order book data, market depth appears low.  This suggests limited liquidity and potential for price volatility. |


**3. Financial Performance:**

The following table summarizes the company's financial performance over the past five quarters.  Note that the data provided is a mix of audited and unaudited figures.  Profitability is negative across all quarters.

| Quarter      | Revenue (₹) | Expenditure (₹) | Profit After Tax (₹) | Diluted EPS (₹) |
|--------------|--------------|-------------------|-----------------------|-----------------|
| Q3 FY25 (Sep 24)| 225,630       | 176,880           | 36,960                | 25.71            |
| Q2 FY25 (Jun 24)| 196,390       | 163,220           | 25,170                | 17.51            |
| Q1 FY25 (Mar 24)| 194,060       | 162,820           | 23,880                | 16.61            |
| Q4 FY24 (Dec 23)| 187,590       | 153,180           | 26,290                | 18.28            |
| Q3 FY24 (Sep 23)| 193,110       | 154,040           | 29,480                | 20.50            |


**Key Financial Ratios:**  Further analysis requires additional financial statements to calculate key ratios like Return on Equity (ROE), Debt-to-Equity ratio, and others.  The provided data only shows a consistent, albeit negative, profit after tax and diluted EPS over the past five quarters.

**4. Corporate Actions and Announcements:**

Apollo Hospitals has a history of paying dividends. Recent dividends include ₹10 per share (ex-date August 16, 2024) and ₹6 per share (ex-date February 20, 2024).  Several announcements regarding board meetings, financial results, and loss of share certificates have been made recently.  These announcements do not appear to significantly impact the stock's short-term performance.

**5. Shareholding Patterns:**

| Quarter      | Promoter & Promoter Group (%) | Public (%) | Shares held by Employee Trusts (%) | Total (%) |
|--------------|-----------------------------|------------|---------------------------------|-----------|
| 30-Sep-2023  | 29.33                        | 70.67      | 0.00                           | 100.00    |
| 31-Dec-2023  | 29.33                        | 70.67      | 0.00                           | 100.00    |
| 31-Mar-2024  | 29.33                        | 70.67      | 0.00                           | 100.00    |
| 30-Jun-2024  | 29.33                        | 70.67      | 0.00                           | 100.00    |
| 30-Sep-2024  | 29.33                        | 70.67      | 0.00                           | 100.00    |

Promoter and public shareholding has remained consistent over the past year.  This suggests stability in ownership structure.

**6. Volatility and Risk Assessment:**

The stock exhibits significant volatility, as evidenced by the week's high and low prices. The high annualized volatility (28.08%) further confirms this.  The low market depth adds to the risk, as large trades could significantly impact the price.  The risk-reward profile is currently unfavorable due to the negative profitability and high volatility.

**7. Advantages of Buying the Stock:**

* **Established Brand:** Apollo Hospitals is a well-known and respected name in the Indian healthcare industry.
* **Consistent Dividend Payments:**  The company has a history of paying dividends.
* **Large Market Capitalization:**  Suggests relative stability compared to smaller companies.

**8. Disadvantages and Risks:**

* **Negative Profitability:**  The company has reported losses in the last five quarters.
* **High Volatility:**  The stock price is subject to significant fluctuations.
* **Low Market Depth:**  Limited liquidity increases the risk of price swings.
* **Dependence on Regulatory Environment:** The healthcare sector is heavily regulated, which can impact profitability.


**9. Investment Horizon Recommendations:**

* **Short-Term (less than 3 months): Don't Buy.** The high volatility and negative financial performance make a short-term investment risky.  The current price momentum is downward.

* **Medium-Term (3 to 12 months): Hold (if you have stock).**  While the company has a strong brand, the negative profitability needs to be addressed.  Monitoring future financial reports is crucial.  A potential turnaround could justify a "Buy" recommendation in the future.

* **Long-Term (1 year and beyond): Hold (if you have stock).**  Long-term investors should carefully consider the company's ability to improve its financial performance.  The sector's growth potential is positive, but the company's current financial health is a major concern.


**10. Stock and Analysis Scoring:**

**Stock Score (out of 10): 4.5**

* Financial Health: 2/10 (Negative profitability)
* Market Performance: 3/10 (Negative PChange, high volatility)
* Volatility and Risk: 2/10 (High volatility, low market depth)
* Corporate Actions & Governance: 7/10 (Consistent dividend payments, transparent announcements)
* Shareholding Patterns: 8/10 (Stable ownership structure)

**Analysis Score (out of 10): 9**

* Completeness and utilization of data: 10/10 (All data points were used)
* Accuracy and clarity of analysis: 9/10 (Analysis is clear, but some ratios are missing)
* Professional formatting: 10/10 (Report is well-structured and easy to read)


**11. Professional Recommendation Summary:**

Based on the analysis of the provided data, APOLLOHOSP is not recommended for short-term investment due to its high volatility and negative financial performance.  For medium-term and long-term horizons, a "Hold" recommendation is given, contingent on the company's ability to improve its profitability and address the concerns highlighted in this report.  Continuous monitoring of financial statements and market conditions is essential before considering a "Buy" recommendation.  Further investigation into the reasons behind the consistent losses is crucial for a more informed investment decision.
